Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1995-06-06
1999-11-30
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
435 691, 4353201, 435325, 514 44, 424 931, A61K 4800
Patent
active
059938005
ABSTRACT:
The invention provides a method for enhancing the expression of a gene of interest by a cell, the cell (a) comprises a recombinant nucleic acid sequence encoding and (b) is capable of expressing the gene of interest, the method comprising contacting the cell with an amount of a soluble CTLA4 molecule effective to enhance the expression of the gene of interest by the cell.
REFERENCES:
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5693622 (1997-12-01), Wolf et al.
patent: 5872154 (1999-02-01), Wilson et al.
Kay et al., PNAS, vol. 84, pp. 4686, 1997.
Gunzberg et al. (Molecular Medicine Today, vol. 1, pp. 410-417, 1995).
Crystal (Science, vol. 270,:404-410, 1995).
Mastrangelo et al. (Seminars in Oncology, vol. 23, No. 1:4-21, 1996).
Linsley et al. (WO 93/00431), Jul. 1993.
Kay et al. (Hepatology, vol. 21, 3:815-819, 1995).
Adam et al., "Identification of a Signal in a Murine Retrovirus that is Sufficient for Packaging of Nonretroviral RNA into Virions", J. Virol. 62:3802-3806 (1988) (Exhibit 2).
Algate et al., "Regulation of the Interleukin-3 (IL-3) in the Fetal Liver-derived F15.12 Cell Line", Blood 83(9):2459-68 (1994) (Exhibit 3).
Armentano et al., "Effect of Internal Viral Squences on the Utility of Retroviral Vectors", J. Virol. 61:1647-1650 (1987) (Exhibit 4).
Bachettis et al., "Transfer of Gene for Thymidine Kinase-Deficient Human Cells by Purified Herpes Simplex Viral DNA", PNAS USA 74:1590 (1977) (Exhibit 5).
Barr et al., "Strain Related Variations in Adenovirally Mediated Transgene Expression from Mouse Hepatocytes in Vivo: Comparisons Between Immunocompetent and Immunodeficient Inbred Strains", Gene Therapy 2:151-155 (1995) (Exhibit 6).
Bender et al., "Evidence that the Packaging Signal of Moloney Murine Leukemia Virus Extends into the GAG Region", J. Virol. 61:1639-1646 (1987) (Exhibit 7).
Berkner, K., "Development of Adenovirus Vectors for Expression of Heterologous Genes", Biotechniques 6:616 (1988) (Exhibit 8).
Biochemical and Biophysical Research Communications 199(1):26-32 (1994) (Exhibit 9).
Breviario et al., "Interleukin-1-Inducible Genes in Endothelial Cells. Cloning of a New Gene Related to C-Reactive Protein and Serum Amyloid P Component", Journal of Biological Chemistry 267(31):22190-7 (1992) (Exhibit 10).
Cluitmans et al., "IL-4-Down-Regulates IL-2, IL-3, and GM-CSF-Induced Cytokine Gene Expression in Peripheral Blood Monocytes", Annals of Hematology 68(6)293-8 (1994) (Exhibit 11).
Culver et al., "Lymphocytes as Cellular Vehicles for Gene Therapy in Mouse and Man", PNAS USA 88:3155 (1991) (Exhibit 12).
Culver et al., "In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors" Cellular Immunology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD. Science 256:1550-1552 (1992) (Exhibit 13).
Danos et al., "Safe and Efficient Generation of Recombinant Retroviruses with Amphotropic and Ecotropic Host Ranges", Proc. Natl. Acad. Sci. USA 85:6460-6464 (1988) (Exhibit 14).
de Wit et al., "Differential Regulation of M-CSF and IL-6 Gene Expression in Monocytic Cells", British Journal of Haematology, 86(2):259-64 (1994) (Exhibit 15).
Eglitis et al., "Retroviral Vectors for Introduction of Genes into Mammalian Cells", Biotechniques 6:608-614 (1988) (Exhibit 16).
Englehardt et al., "Ablation of E2A in Recombinant Adenoviruses Improves Transgene Persistence and Decreases Inflammatory Response in Mouse Liver", Proc. Natl. Acad. Sci. USA 91:6196 (1994) (Exhibit 17).
Espinoza-Delgado et al., "Regulation of IL-2 Receptor Subunit Genes in Human Monocytes. Differential Effects of IL-2 and IFN-gamma", Journal of Immunology 149(9):2961-8 (1992) (Exhibit 18).
Finck et al., "Treatment of Murine Lupus with CTLA4Ig", Science 265:1225 (1994) (Exhibit 19).
Freireich et al., "Quantitative Comparison of Toxicity of Anticancer Agents in Mouse, Rat, Hamster, Dog, Monkey, and Man", Cancer Chemotherapy Re/ 50(4):219-244 (1966) (Exhibit 20).
Friedman, T. "Progress Toward Human Gene Therapy", Science 244:1275-1281 (1989) (Exhibit 21).
Geller et al., "An Efficient Deletion Mutant Packaging System for a Defective Herpes Simplex Virus Vectors: Potential Applications to Human Gene Therapy and Neuronal Physiology", PNAS USA 87:8950 (1990) (Exhibit 22).
Ghosh-Choudhury et al., "Human Adenovirus Cloning Vectors Based on Infectious Bacterial Plasmids", Gene 50:161 (1986) (Exhibit 23).
Gilboa et al., "Transfer and Expression of Cloned Genes Using Retroviral Vectors", Biotechniques 4:504-512 (1986) (Exhibit 24).
Guild et al., "Development of Retrovirus Vectors Useful for Expressing Genes in Cultured Murine Embryonic Cells and Hematopoietic Cells in Vivo", J. Virol. 62:795 (1988) (Exhibit 25).
Hag-Ahmand et al., "Development of Helper-Independent Human Adenovirus Vector and Its Use in the Transfer of the Herpes Simplex Virus Thymidine Kinase Gene", J. Virol. 57:257 (1986) (Exhibit 26).
Hock et al., "Retrovirus Mediated Transfer and Expression of Drug Resistance Genes in Human Hemopoietic Progenitor Cells", Nature 320:275 (1986) (Exhibit 27).
Horisberger et al., "Cloning and Sequence Analyses of cDNAs for Interferon- and Virus-Induced Human Mx Proteins Reveal that they Contain Putative Guanine Nucelotide-Binding Sites: Functional Study of the Corresponding Gene Promoter", Journal of Virology 64(3):1171-81 (1990) (Exhibit 28).
Karson, E., "Prospects for Gene Therapy", Biol. Reprod. 42:39 (1990) (Exhibit 29).
Kaufman, R., "Identification of the Component Necessary for Adenovirus Translational Control and Their Utilization in cDNA Expression Vectors", PNAS USA 82:689 (1985) (Exhibit 30).
Kay, et al., "Therapeutic Serum Concentrations of Human Alpha-1-Antitrypsin After Adenoviral-Medicated Gene Transfer Into Mouse Hepatocytes", Hepatology 1, 431 (1981) (Exhibit 31).
Kay et al., "Messenger RNA Expression of the Cytokine Gene Cluster, Interleukin 3(IL-3), IL-4, IL-5, and Granulocyte/Macrophage Colony-Stimulating Factor, in Allergen-Induced Late-Phase Cutaneous Reactions in Atopic Subjects", Journal of Experimental Medicine, 173(3):775-8 (1991) (Exhibit 32).
Kay et al., "In Vivo Hepatic Gene Therapy: Complete Albeit Transient Correction of Factor IX Deficiency in Hemophilia B Dogs", Proc. Natl. Acad. Sci. USA 91, 2353 (Exhibit 33).
Knodell et al., "Formulation and Application of a Numerical Scoring System for Assessing Histological Activity in Asymptomatic Chronic Alive Hepatitis", Hepatology 1, 431 (Exhibit 34).
Lagoo et al., "IL-2, IL-4 and IFN-gamma Gene Expression Versus Secretion in Superantigen-Activated T Cells. Distinct Requirement for Costimulatory Signals Through Adhesion Molecules", Journal of Immunology 152(4):1641-52 (1994) (Exhibit 35).
Lewis, et al., "Interleukin 4 Expressed In Situ Selectively Alters Thymocyte Development", J. Exp. Med. 173:89-100 (1991) (Exhibit 36).
Li et al., "Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy", Human Gene Therapy 4, 403 (1993) (Exhibit 37).
Li et al., "Proinflammatory Cytokines Tumor Necrosis Factor-alpha and IL-6 but not IL-1, Down-Regulate the Osteocalcin Gene Promoter", Journal of Immunology 148(3):788-794 (1992) (Exhibit 38).
Linsley et al., "Binding of the B Cell Activation Antigen B7 to CD28 Costimulates T Cell Proliferation and Interleukin 2 mRNA Accumulation", J. Exp. Med. 173:721-730 (1991) (Exhibit 39).
Linsley et al., "Immunosuppression in Vivo by a Soluble Form of the CTLA4 Cell Activation Molecule", Science 257(5071)792-795 (1992) (Exhibit 40).
Linsley et al., "The Role of the CD28 Receptor During T Cell Responses to Antigen", Annu. Rev. Immunol. 11:191-212 (1993). (Exhibit 41).
Markowitz et al., "Construction and Use of a Safe and Efficient Amphotropic Packaging Cell Line", Virology 167:400-406 (1988) (Exhibit 42).
Martinez et al., Il-2 and Il-5 Gene Expression in Response to Alloantigen in Liver Allograft Recipients and in Vitro, Transplantation 55(5):1159-66 (1993) (Exhibit 43).
Mauviel et al., "Leukoregulin, A T Cell-Derived Cytokine, Induces Il-8 Gene Expression and Secretion in Human Skin Fibroblasts", Journal of Immunology 149(9):2969-76 (
Aruffo Alejandro A.
Hollenbaugh Diane L.
Kay Mark A.
Ledbetter Jeffrey
Linsley Peter S.
Bristol--Myers Squibb Company
Campell Bruce R.
Nguyen Dave Trong
LandOfFree
Methods for prolonging the expression of a heterologous gene of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for prolonging the expression of a heterologous gene of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for prolonging the expression of a heterologous gene of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1668006